Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Holding CRSP?
Track your performance easily

Crispr Therapeutics AG (CRSP) Balance Sheet

8,414 Followers

Crispr Therapeutics AG Balance Sheet

Crispr Therapeutics AG's total assets for Q2 2024 were $2.34B, a decrease of -4.07% from the previous quarter. CRSP total liabilities were $358.90M for the fiscal quarter, a 1.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 2.23B$ 2.24B$ 2.75B$ 1.83B$ 1.07B
Total Liabilities
$ 346.77M$ 367.58M$ 352.42M$ 163.73M$ 127.33M
Total Equity Gross Minority
$ 1.88B$ 1.88B$ 2.40B$ 1.66B$ 939.42M
Total Capitalization
$ 2.11B$ 2.10B$ 2.40B$ 1.66B$ 939.42M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 61.43M$ 52.54M
Currency in USD

Crispr Therapeutics AG Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis